APA

De Monte A., Brunetti D., Cattin L., Lavanda F., Naibo E., Malagoli M., Stanta G. & Bonin S. (2018). Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients. : Molecular and clinical oncology.

Chicago

De Monte Ariella, Brunetti Davide, Cattin Luigi, Lavanda Francesca, Naibo Erica, Malagoli Maria, Stanta Giorgio and Bonin Serena. 2018. Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients. : Molecular and clinical oncology.

Harvard

De Monte A., Brunetti D., Cattin L., Lavanda F., Naibo E., Malagoli M., Stanta G. and Bonin S. (2018). Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients. : Molecular and clinical oncology.

MLA

De Monte Ariella, Brunetti Davide, Cattin Luigi, Lavanda Francesca, Naibo Erica, Malagoli Maria, Stanta Giorgio and Bonin Serena. Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients. : Molecular and clinical oncology. 2018.